GILL JOHN 4
4 · Altimmune, Inc. · Filed Sep 29, 2025
Insider Transaction Report
Form 4
GILL JOHN
Director
Transactions
- Award
Stock Options (option to buy)
2025-09-25+48,800→ 48,800 totalExercise: $3.92Exp: 2035-09-25→ Common Stock, par value $0.0001 (48,800 underlying) - Gift
Common Stock, par value $0.0001
2022-01-06−2,714→ 0 total
Footnotes (3)
- [F1]Represents a bona fide gift of 2,714 shares of common stock made on January 6, 2022.
- [F2]Certain Section 16 reports previously filed by the reporting person inadvertently overstated the reporting person's direct common stock ownership by 57 shares. As of the date of this filing, the reporting person does not hold any shares of common stock directly or indirectly.
- [F3]The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 25, 2025, subject to the reporting person's continued service through the applicable vesting date.